Company Data

Atreca Inc.

Ticker
BCEL
Current Price
$0.09
Market Cap
$3.6M
Price Target
Refer to Report
Volume
836.1K
52wk Range
$0.052 - $1.0019
Advanced Market Data

Overview

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company’s product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy